PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon
IJC Heart & Vasculature · 2025-10 · 60 · 101762
DOI: 10.1016/j.ijcha.2025.101762 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJC Heart & Vasculature, 2025-10. Verfasst von Xinyi Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan 430062, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhongnan Hospital of Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Chronic total occlusion (CTO) of coronary arteries is a significant challenge in percutaneous coronary intervention (PCI). Despite successful revascularization, patients often develop diffuse coronary lesions, increasing the risk of restenosis and necessitating complex stent strategies.
Objective
This study aimed to compare the clinical outcomes of drug-eluting stents (DES) combined with drug-coated balloon (DCB) angioplasty versus DES-only treatment in patients with revascularized CTO and diffuse coronary artery disease.
Methods
Patients with successfully revascularized CTO and diffuse lesions were divided into DES-only (n = 191) and DES plus DCB (n = 100) groups. The primary endpoint was major adverse cardiovascular events (MACE), including all-cause death, cardiac death, stroke, and revascularization. The secondary endpoint was the rate of cardiovascular-related hospitalization. Symptom improvement was evaluated using the Canadian Cardiovascular Society (CCS) classification.
Results
At 24-month follow-up, the DES plus DCB group had significantly lower MACE incidence (26.00 % vs. 41.36 %, P = 0.008) and cardiovascular-related hospitalization (20.00 % vs. 36.65 %, P = 0.005) compared to the DES-only group. CCS classification improved more significantly in the DES plus DCB group (P < 0.001). Multivariate Cox regression identified DES plus DCB as an independent protective factor against MACE (HR, 0.57; 95 % CI, 0.33-0.99; P = 0.046).
Conclusion
In patients with revascularized CTO and diffuse coronary artery disease, the combined DES plus DCB strategy was associated with a lower incidence of MACE and reduced cardiovascular-related hospitalization compared to DES-only treatment. This approach may represent a superior therapeutic option for managing complex coronary lesions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan 430062, China.
- Institute of Myocardial Injury and Repair, Wuhan University, Wuhan 430062, China.
Förderung
- Zhongnan Hospital of Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Yan, X., Gao, X., Hu, Y., Cao, J., Zhang, W., Lu, Y., Zhou, J., Wu, Q., & Hu, X. (2025). PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon. IJC Heart & Vasculature, 60, 101762. https://doi.org/10.1016/j.ijcha.2025.101762
Vancouver
Yan X, Gao X, Hu Y, Cao J, Zhang W, Lu Y, et al. PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon. IJC Heart & Vasculature. 2025;60:101762. doi:10.1016/j.ijcha.2025.101762
BibTeX
@article{Yan2025,
author = {Yan, Xinyi and Gao, Xinchen and Hu, Yingying and Cao, Jianlei and Zhang, Wei and Lu, Yi and Zhou, Jia and Wu, Qingqing and Hu, Xiaorong},
title = {PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon},
journal = {IJC Heart & Vasculature},
year = {2025},
volume = {60},
pages = {101762},
doi = {10.1016/j.ijcha.2025.101762}
}
EUVIMED